ATRC Stock Summary and Trading Ideas (Atricure | NASDAQ:ATRC)

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Atricure trades on the NASDAQ stock market under the symbol ATRC.

As of April 17, 2024, ATRC stock price climbed to $23.45 with 640,042 million shares trading.

ATRC has a beta of 1.85, meaning it tends to be more sensitive to market movements. ATRC has a correlation of 0.19 to the broad based SPY ETF.

ATRC has a market cap of $1.12 billion. This is considered a Small Cap stock.

Last quarter Atricure reported $107 million in Revenue and -$.21 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.02.

In the last 3 years, ATRC stock traded as high as $89.18 and as low as $22.42.

The top ETF exchange traded funds that ATRC belongs to (by Net Assets): VTI, VB, IWM, VXF, VBK.

ATRC has underperformed the market in the last year with a price return of -44.8% while the SPY ETF gained +23.0%. ATRC has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.8% and -13.8%, respectively, while the SPY returned +5.7% and -3.5%, respectively.

ATRC support price is $22.30 and resistance is $23.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ATRC stock will trade within this expected range on the day.